Tailored Antiplatelet Rx in Complex PCI: TAILORED-CHIP 09/01/25
Welcome to Cardiology Today – Recorded September 01, 2025. This episode summarizes 1 key cardiology studies on topics like atrial fibrillation and heart failure. Key takeaway: Biomarker-guided treatments show no outcome benefits.
Article Links: Article 1: Temporal modulation of antiplatelet therapy in high-risk patients undergoing complex percutaneous coronary intervention: the TAILORED-CHIP randomized clinical trial. (European heart journal)
Tap ‘more’ for full notes and links. Full episode page: https://podcast.explainheart.com/podcast/tailored-antiplatelet-rx-in-complex-pci-tailored-chip-09-01-25/
đ Full Episode Summary
This episode covers recent research from top journals like NEJM and JACC. Tap ‘more’ for details.
đ Featured Articles
Article 1: Temporal modulation of antiplatelet therapy in high-risk patients undergoing complex percutaneous coronary intervention: the TAILORED-CHIP randomized clinical trial.
Journal: European heart journal
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40886179
Summary: This trial evaluated a tailored antiplatelet strategy, modulating platelet inhibition intensity, in high-risk patients undergoing complex PCI. The study’s findings will likely influence future antiplatelet guidelines for this specific patient population.
đ Transcript
Today’s date is September 01, 2025. Welcome to Cardiology Today. Here are the latest research findings.
Article number one. Temporal modulation of antiplatelet therapy in high-risk patients undergoing complex percutaneous coronary intervention: the TAILORED-CHIP randomized clinical trial. This trial evaluated a tailored antiplatelet strategy, modulating platelet inhibition intensity, in high-risk patients undergoing complex PCI. The study’s findings will likely influence future antiplatelet guidelines for this specific patient population.
Thank you for listening. Tap ‘more’ for full notes and links.
đ Keywords
Cardiology, Heart Disease, Clinical Research, NEJM, JACC.
âšī¸ About
Concise summaries of cardiovascular research for professionals.
Subscribe âĸ Share âĸ Follow